Sandro Pontremoli

Sandro Pontremoli

Auto-generated profile, based on publicly available information

Sandro Pontremoli

Department of Experimental Medicine (DIMES)-Biochemistry Section, and Centre of Excellence for Biomedical Research (CEBR), University of Genoa, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 1996 in FEBS Letters
Verified
Journal Article
Open access
PDF file
MMMauro Michetti
Mauro Michetti
FSFranca Salamino
Franca Salamino
ITIlaria Tedesco
Ilaria Tedesco
MONICA AVERNAMONICA AVERNA
MONICA AVERNA
RMRoberto Minafra
Roberto Minafra
SPSandro Pontremoli
Sandro Pontremoli
The 80 kDa human erythrocyte calpain, when exposed to Ca2+, undergoes autoproteolysis that generates a 75 kDa species, with an increase in Ca2+ affinity. It is demonstrated here that this proteolytic modification proceeds through an initial step producing a 78 kDa form which is rapidly converted to the 75 kDa one. In the presence of the calpain inhibitor E‐64, the 78 kDa form accumulates and only small amounts of the 75 kDa polypeptide are formed. Following loading of erythrocytes with micromolar concentration of Ca2+, in the presence of the ionophore A23187, the native 80 kDa calpain subunit is extensively translocated and retained at the plasma membrane, this process is accompanied by the appearance of only a small amount of the 75 kDa subunit which is released into the soluble fraction of the cells. Following exposure to μM Ca2+, membrane‐bound 80 kDa calpain is converted to the 78 kDa form, this conversion being linearly correlated with the expression of the proteinase activity. Taken together, these results demonstrate that the initial step in calpain activation involves Ca2+‐induced translocation to the inner surface of plasma membranes. In the membrane‐bound form the native inactive 80 kDa subunit is converted through intramolecular autoproteolysis to a locally active 78 kDa form. Further autoproteolytic intermolecular digestion converts the 78 kDa to the 75 kDa form, no longer being retained by the membrane. This process generates two active forms of calpain, with different intracellular localisations.

29 October 2007 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
MONICA AVERNAMONICA AVERNA
MONICA AVERNA
RSRoberto Stifanese
Roberto Stifanese
RTRoberta De Tullio
Roberta De Tullio
FSFranca Salamino
Franca Salamino
MBMara Bertuccio
Mara Bertuccio
EMEdon Melloni
Edon Melloni
Ca2+ loading of Jurkat and bovine aorta endothelium cells induces the degradation of the neuronal and endothelial nitric oxide synthases that are selectively expressed in these cell lines. For neuronal nitric oxide synthase, this process involves a conservative limited proteolysis without appreciable loss of catalytic activity. By contrast, endothelial nitic oxide synthase digestion proceeds through a parallel loss of protein and catalytic activity. The chaperone heat shock protein 90 (HSP90) is present in a large amount in Jurkat cells and at significantly lower levels in bovine aorta endothelium cells. The differing ratios of HSP90/nitric oxide synthase (NOS) occurring in the two cell types are responsible for the conservative or nonconservative digestion of NOS isozymes. Consistently, we demonstrate that, in the absence of Ca2+, HSP90 forms binary complexes with NOS isozymes or with calpain. When Ca2+ is present, a ternary complex containing the three proteins is produced. In this associated state, HSP90 and NOS forms are almost completely resistant to calpain digestion, probably due to a structural hindrance and a reduction in the catalytic efficiency of the protease. Thus, the recruitment of calpain in the HSP90–NOS complexes reduces the extent of the proteolysis of these two proteins. We have also observed that calpastatin competes with HSP90 for the binding of calpain in reconstructed systems. Digestion of the proteins present in the complexes can occur only when free active calpain is present in the system. This process can be visualized as a novel mechanism involving the association of NOS with HSP90 and the concomitant recruitment of active calpain in ternary complexes in which the proteolysis of both NOS isozymes and HSP90 is significantly reduced.

18 April 2008 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
MONICA AVERNAMONICA AVERNA
MONICA AVERNA
RSRoberto Stifanese
Roberto Stifanese
RTRoberta De Tullio
Roberta De Tullio
FSFranca Salamino
Franca Salamino
SPSandro Pontremoli
Sandro Pontremoli
EMEdon Melloni
Edon Melloni
We have shown previously that isolated heat shock protein 90 (HSP90) and nitric oxide synthase (NOS), once associated in a heterocomplex, become completely resistant to calpain digestion. In this study, it is shown that, in vivo, under conditions of calpain activation, the protection of NOS degradation occurs. In addition, the extent of NOS degradation is a function of the level of HSP90 expression. Thus, in rat brain, which contains a large excess of HSP90, almost all neuronal NOS is associated with the chaperone protein. In this condition, neuronal NOS retains its full catalytic activity, although limited proteolytic conversion to still active low‐molecular‐mass (130 kDa) products takes place. In contrast, in aorta, which contains much smaller amounts of HSP90, endothelial NOS is not completely associated with the chaperone, and undergoes extensive degradation with a loss of protein and catalytic activity. On the basis of these findings, we propose a novel role of the HSP90–NOS heterocomplex in protecting in vivo NOS from proteolytic degradation by calpain. The efficiency of this effect is directly related to the level of intracellular HSP90 expression, generating a high HSP90 to NOS ratio, which favours both the formation and stabilization of the HSP90–NOS heterocomplex. This condition seems to occur in rat brain, but not in aorta, thus explaining the higher vulnerability to proteolytic degradation of endothelial NOS relative to neuronal NOS.

20 May 1996 in FEBS Letters
Verified
Journal Article
Open access
PDF file
BSBianca Sparatore
Bianca Sparatore
EMEdon Melloni
Edon Melloni
Mauro PatroneMauro Patrone
Mauro Patrone
MPMario Passalacqua
Mario Passalacqua
SPSandro Pontremoli
Sandro Pontremoli
Murine erythroleukemia (MEL) cells, in addition to an mRNA coding for a 30 kDa high mobility group (HMG)‐1 protein, contain an mRNA coding for a 6 kDa HMG1 protein having the following structural properties: (1) its primary structure has 90% homology with the N‐terminal sequence of the 30 kDa HMG1 protein; (2) it contains a consensus region of the HMG1 protein family; (3) it is deprived of the cluster of acidic amino acids that characterizes the C‐terminal region of the 30 kDa HMG1 protein. This novel small M r HMG1 protein has been expressed in prokaryotic cells and tested to establish similarities and differences in activity compared to the homologous higher M r HMG1 protein. It has been found that the low M r HMG1 form is not released from MEL cells following induction to erythroid differentiation, but is still effective, although with much less efficiency, when added to the external medium, in promoting acceleration in the rate of MEL cell differentiation as well as in activation of α‐protein kinase C. Altogether these results provide evidence for the presence in MEL cells of a multigene family that encodes at least two different HMG1‐type sequences most presumably involved, at distinct cellular sites, in different functions although commonly related to the promotion of cell differentiation. Additional information can be considered concerning the relationship between the characteristic N‐terminal sequence of HMG1 protein and the extracellular activity on MEL cell differentiation.

31 March 2006 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
MONICA AVERNAMONICA AVERNA
MONICA AVERNA
RSRoberto Stifanese
Roberto Stifanese
RTRoberta De Tullio
Roberta De Tullio
EDEnrico Defranchi
Enrico Defranchi
FSFranca Salamino
Franca Salamino
SPSandro Pontremoli
Sandro Pontremoli
Conformational changes in the calpain molecule following interaction with natural ligands can be monitored by the binding of a specific monoclonal antibody directed against the catalytic domain of the protease. None of these conformational states showed catalytic activity and probably represent intermediate forms preceding the active enzyme state. In its native inactive conformation, calpain shows very low affinity for this monoclonal antibody, whereas, on binding to the ligands Ca2+, substrate or calpastatin, the affinity increases up to 10‐fold, with calpastatin being the most effective. This methodology was also used to show that calpain undergoes similar conformational changes in intact cells exposed to stimuli that induce either a rise in intracellular [Ca2+] or extensive diffusion of calpastatin into the cytosol without affecting Ca2+ homeostasis. The fact that the changes in the calpain state are also observed under the latter conditions indicates that calpastatin availability in the cytosol is the triggering event for calpain–calpastatin interaction, which is presumably involved in the control of the extent of calpain activation through translocation to specific sites of action.